Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients

Summary

The purpose of this study is to determine if a safe reduction of cyclosporine A in pediatric and adolescent patients with stable renal graft function, reduces signs of calcineurin-inhibitor toxicity.

Timeline

Start

2008-12

Primary completion

2012-12

Completion

2013-06

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to methodological reasons.”

Drugs

Indications

No indication recorded.